ABSTRACT OBJECTIVES This paper reports the development, validation, and public availability of a new neural network-based system which attempts to identify the manufacturer and even the model group of a pacemaker or defibrillator from a chest radiograph.
the corresponding communication equipment to the bedside.
Unless they have access to the records of the implanting hospital or the patient can tell them, staff must use a process of trial and error to identify the manufacturer, which causes uncertainty and leads to delays which can be medically harmful.
Experts can sometimes distinguish among devices from a chest radiograph, and algorithms are available to assist with this. However, expertise or confidence in using the algorithm are not widespread, and even with the best available algorithm, identification is not perfect. Indeed, up to 80% of physicians report having "frequently" had difficulties identifying devices (3) .
The most recent algorithm for visual discrimination among devices shown on a chest radiograph is 8 years of age (3) and therefore does not include current devices. Even at that time, the study authors reported only 90% accuracy in identifying the manufacturer.
The present study reports the development, validation, and public availability of a new neural network-based system which attempts to identify the manufacturer and even the model group of a device by using a chest radiograph. 
METHODS

FIGURE 1 Study Design Flowchart
The study was designed in 3 phases consisting of data collection, development of the neural network, and assessment of the network.
Development of the neural network was divided into 2 stages. Stage 1 involved selecting the optimal network design. Stage 2 involved training the "final" model, which is then assessed using the unseen "test set", allowing a comparison with humans. 
A B B R E V I A T I O N S
therefore, only device models were included for which there were at least 25 chest radiographic images available. Both portable and departmental anterior-posterior/posterior-anterior (AP/PA) chest radiographs were included. Lateral chest radiographs were not included. In the absence of any data outlining the prevalence of different devices across the world, a dataset was generated in which all types of device were represented in equal proportions. Images were extracted from consecutive patients to a maximum of 40 images per model to minimize class imbalance (4) . From each radiographic image, a square region of interest slightly larger than the device was extracted. This region maximized the signalto-noise ratio for the network and guaranteed anonymization. These cropped images were then resized to 224 Â 224 pixels and normalized to yield pixel values between 0 and 1. It was noted during extraction that, in several cases, when a manufacturer introduced a new model, there was no detectible change on the radiograph. This may represent purely a change in software or an indistinguishable replacements of parts; therefore, models with identical appearance were placed in "model groups."
The first step was to randomly allocate 5 images from each of the 45 classes to be kept aside as the final "test set." This would not be shown to the network at any stage in its training and would only be used once when reporting its final accuracy.
The remaining "training set" was used to train the network at 2 different stages. The first stage was to decide which underlying network to use (including structural features such as the number and size of layers) and details of how the training process would run (including the avidity with which synapses are adjusted, termed the "learning rate"). All tested neural networks were convolutional neural networks which contain neurons that learn to recognize specific features within their own "visual fields." These networks are organized in a hierarchical structure akin to the human optic cortex and excel at solving image classification problems (5-9). The second stage was the detailed process of adjusting the weights (akin to the synapses in a biological neural network) so that the job of classifying pacemakers could be performed. Both stages used the training set but in different ways.
For the first stage ("network design") ( Figure 1) , each candidate neural network design was assessed by its ability to learn from 75% of the training set and correctly make predictions for the remaining 25% of the training set. This was done 4 times, so that all of the training set could participate in turn in both roles.
This process is termed "4-fold cross-validation" (unrelated to the final testing which is performed using a completely separate test set). Finally, this final network is exposed for the first time to the "test set," which has been kept separate Howard et al.
Identifying Cardiac Devices From X-rays With AI VISUALIZATION OF LEARNING. Examples of each model group were processed to provide saliency maps (13) where the pixels with the highest gradient with regard to the correct class (i.e., the pixels contributing most to the decision of the network)
were highlighted. This was performed using Keras-vis software (14) . Thirty-eight radiographs (16.9%) were portable radiographs. The remaining 1,451 cases were assigned to the training set. The study flow chart is shown in Figure 1 . Finally, the "test set" of data which had been set aside until now was tested, once, using the final neural network produced by stage 2. To demonstrate the utility of saliency mapping, In Figure 3 , most humans and, indeed most expert cardiologists, have difficulty in differentiating between the 2 models of pacemaker. However, not only does the neural network accurately distinguish between them but the saliency map highlights the feature that distinguishes them most clearly. Moreover, once this salient feature is pointed out to humans (Figure 4) , they now find it straightforward to make the distinction.
Online Appendix 3 shows saliency maps for every model group. Studying these may assist clinicians by using it to sharpen their eye for cardiac device identification. Saliency plots from the neural network can help guide us where to look. The answer to the question in Figure 2 is C. Saliency plots reveal that the network is focusing on a feature present in the AT500s (red circles), which is absent in the Advisas. Having this pointed out by the network now makes it easy to return to Figure 3 and correctly categorize them. These example images also demonstrate the neural network's ability to deal with dramatic differences in image quality, radiography, penetration, and orientation.
Howard et al.
Identifying Cardiac Devices From X-rays With AI Deployment from "bench to bedside" can be difficult with neural networks, because the large processing power needed is not always present at the point of care. This was mitigated by providing an online Web portal that anyone could use (19) .
CONCLUSIONS
This study demonstrates a convolutional neural network is able to accurately identify the manufacturer and model of a cardiac rhythm device from a radiograph. Furthermore, its performance significantly exceeds that of a cardiologist using a flowchart approach.
